Nabi Biopharmace (NABI)

Watch the video to learn about the probability of Nabi Biopharmace (NABI) Chart Signal as of Sep 01, 2014

Hotstocked Precision will calculate the probabilities of Nabi Biopharmace (NABI)

Rating:
Size: 656KB
Version: 1.1
Platform: Win/Mac
Downloads: 800,000+
FREE DOWNLOAD

QUOTE

As of 09:54PM EDT September 01, 2014
$ N/A   N/A (N/A%)
Today's Open: N/A Previous Close: N/A
Today's High: N/A Volume: N/A
Today's Low: N/A Avg Vol: N/A
52 Week High: N/A Bid (size): N/A
52 Week Low: N/A Ask (size): N/A

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: -
Mailing Address: 12270 WILKINS AVENUE ROCKVILLE MD 20852 Business Address 12270 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099 Biota Pharmaceuticals, Inc. CIK #: 00
Phone: 301-770-3099
Fax: 301-770-3097
Website: http://www.nabi.com

Company Details:

Symbol: NABI
SIC: 72444
State location: MD
Sector: -
State of Inc: DE
Employees: 42
Type: NASDAQ

Key executives:

Name Age Position

Watch the video to learn about the probability of Nabi Biopharmace (NABI) Chart Signal as of Sep 01, 2014

This free program will calculate the probabilities of Nabi Biopharmace (NABI) stock chart

Rating: Platform: Win/Mac
Price: FREE Version: 1.1
Size: 656KB Downloads: 800,000+
FREE DOWNLOAD

LATEST ARTICLES

The Technical Side of (NASDAQ: NABI), (OTCBB: CHGY) and (OTCBB: AAPH) February 24, 2010

Ben Bernanke's assurance the tightened monetary policy won't be put in action if inflation stays in line calmed down the market on Wednesday and we had a nice little run up. A few of the more interesting stocks that celebrated the run up are below. read more

LATEST STOCK PROMOTIONS

2nd week November: Portfolio Maintenance Nov 10, 2011, 14:46

  Sell Nabi BioPharma (NABI) 10 November 2011; market open (The previous issue was broadcast on 11/4/11) Preemptive Profit-Positioning: Nabi BioPharma (NABI: Nasdaq): $1.93 X $1.95   Shares of Nabi BioPharma (NABI) have been unable to recover from the disappointing results it received from a key Phase III clinical trial for its smoking-cessation treatment NicVAX in July. A second clinical trial recently completed on the drug read more

Promoter: Contrarian Press Paying Party: UNKNOWN Max Profit: 6.42% Gain at close: 2.14%
Stock: NABI Compensation: Unknown compensation Avg $ Volume for Period: UNKNOWN

Nabi Biopharmace (NABI) MESSAGE BOARD

Post # Subject Re Name Date
1 How do you do? Is anyone in here? Do you... 0
2 Here on this message board we are inviting... 0